Start with your question.
Your candidate pool, investigation capacity and next decision define the scope. There is no one-size-fits-all shortlist.
↗
Candidate selection · Pharma & biotech
See the potential. Choose what’s next.
AIS is developing a way to turn your molecular candidates and existing evidence into a focused shortlist—with clear reasons, uncertainty and the final decision in your experts’ hands.
Why AIS
You can’t investigate
every candidate.
Where do you focus?
Every next step takes time, expertise and resources. When the pool is wide, choosing where to look more closely becomes a research question of its own.
We’re developing shortlist support around that decision. You bring the candidate pool and the evidence. The proposed return is a focused selection, a readable brief and the reasoning behind each choice.
Explore what’s included ↗A thoughtful approach
Fewer candidates.
More clarity around each one.
See the reasoning.
Understand what supports a choice, what was excluded and where the evidence remains uncertain.
↗Decide with your experts.
Your scientists assess the shortlist and decide what deserves further investigation, including any microdosing or other next-stage work.
↗A simple example: a team with 100 candidates might have the capacity to investigate 10. That illustrates the decision—not a fixed ratio, a result or a clinical eligibility claim.
A clearer picture
More than a name
on a shortlist.
A useful brief should help people ask better questions. See how the proposed format brings candidates, reasons and unresolved gaps into one view.
A matching structured file lets your tools read the same evidence.
All sample records are fictional. They demonstrate the format, not scientific performance.
Built around your team
A shared view.
Different perspectives.
From the scientist reviewing a candidate to the colleagues assessing an engagement, everyone needs a clear picture of the same offer.
Find your perspective ↗Research & translationData & computationPortfolioBusiness developmentLegal & securityProcurement
Evidence first.
Always.
A clear research question, traceable sources and an agreed evaluation help your team judge the usefulness of a shortlist.
Our approach to evidence ↗Begin with your question
Good science starts
with a conversation.
Tell us what you have in mind.
Contact us